Consequently, our results demonstrated the pro-malignant role of the CCL7/CCR3 axis and suggested that targeting this axis could be an effective method to inhibit the metastatic spread of ovarian cancer cells by regulating the tumor microenvironment. This evidence concerns the gene CCR3 and ovarian carcinoma.